Accession Number: | 0001209191-23-002778 |
Date: | 2023-01-06 |
Issuer: | CINCOR PHARMA, INC. (CINC) |
Original Submission Date: |
ALLISON DAVID D.
C/O CINCOR PHARMA, INC.
230 THIRD AVENUE, 6TH FLOOR
WALTHAM, MA 02451
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 11.78 | 2023-01-06 | deemed execution date | A | 1,499 (a) | 2023-01-06 | 2033-01-05 | common stock 1,499 | $11.78 | 1,499 | direct |
ID | footnote |
---|---|
f1 | this option was issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of retainer fees of $12,500. |